Open access
1,416
Views
0
CrossRef citations to date
0
Altmetric
Original Research
A projected cost-utility analysis of avacopan for the treatment of antineutrophil cytoplasmic antibody-associated vasculitis in Spain
Manuel Macíaa Nephrology Service, Hospital Universitario Nuestra Señora de Candelaria, Santa Cruz de Tenerife, SpainView further author information
, Montserrat Díaz-Encarnaciónb Nephrology Service, Fundació Puigvert, Barcelona, SpainView further author information
, Roser Solans-Laquéc Internal Medicine Department, Hospital Valle de Hebrón, Barcelona, SpainView further author information
, Elisenda Pomares Mallold Market Access, PharmaLex, Barcelona, SpainCorrespondence[email protected]
View further author information
, View further author information
Alejandra García Castellsd Market Access, PharmaLex, Barcelona, SpainView further author information
, Cristina Escribanoe Medical Department, CSL Vifor, Barcelona, SpainView further author information
& Antonio Ramírez de Arellanof HEOR, CSL Vifor, Zürich, SwitzerlandView further author information
show all
Pages 227-235
|
Received 27 Oct 2023, Accepted 15 Dec 2023, Published online: 25 Dec 2023
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.